LEVILACTOBACILLUS BREVIS CD2
UNII F9N9W3DON7

Substance Identification & Data

This profile provides standardized clinical and technical data for Levilactobacillus Brevis Cd2, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F9N9W3DON7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
F9N9W3DON7
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LEVILACTOBACILLUS BREVIS CD2
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levilactobacillus Brevis Cd2. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

L. BREVIS STRAIN CD2
LACTOBACILLUS BREVIS CD2
LEVILACTOBACILLUS BREVIS CD2

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record